| At present,for China's pharmaceutical industry,it is in a critical period to upgrade industry and adjust structure.And it has existed in a long time to have the problems of unreasonable structure in its development.It must be done to accelerate industrial upgrading,and to promote enterprise research and innovation.Otherwise,The Big Health Industry has had a huge market in China,which is expected to reach16 trillion ? by 2030.Thus,it will face a huge opportunity of strategic development for the enterprises which have forward-looking layout,a large size,and an innovative capacity.The W Pharmaceutical Corp.is the largest professional infusion manufacturer and the largest antibiotic producer in the world.It has had an annual sales revenue of over 40 billion ?,which is ranking among the top three in China's pharmaceutical manufacturing industry.So far,the W has been unswervingly following the path of innovation-driven development,constantly improving and enriching its product line,serving clinical patients with higher quality,and striving to improve people's health and well-being.This thesis takes the W as the research object,for which has had both extensive representativeness and good practical significance.There are seven chapters in this article.First of all,the introduction part introduces the background and the significance,research status at home and abroad,research methods and framework,and review the theory and relevant literature.Secondly,it introduces the basic situation of the W,including the company profile,development strategy,development status and trend,and analyzes the internal and external environment,as well as the company's advantages,disadvantages,opportunities and challenges.Thirdly,it formulates the W's development strategy,and constructs its strategic support system.The aim of this article is hoped to provide reference for the W.At the same time,it's also hoped to provide valuable reference for other pharmaceutical enterprises. |
PDF Full Text Request